The sensitivity of human blood platelets to the aggregating agent ADP during different dietary sodium intakes in healthy men
- 43 Downloads
We have investigated the effect of varying sodium intake on the renin-angiotensin system, ADP-induced patelet aggregationin vitro, and blood 5-HT concentrations in 9 male volunteers.
Systolic blood pressure was slightly reduced during a low sodium diet, whereas the diastolic pressure remained unchanged. Plasma renin activity and aldosterone concentration both fell significantly when sodium intake was increased; plasma angiotensin lI concentraion also fell, but not significantly.
There was a significant fall in haematocrit after an increased sodium intake, but there was no change in the whole-blood platelet count after correcting for this. There were no significant changes in either total (i. e. PRP) or platelet 5-HT concentrations.
The extent of platelet aggregation induced by 5 and 20 μmol · 1−1 of ADP increased significantly when dietary sodium intake was increased. When compared with low or normal sodium intakes, lower concentrations of ADP were required to produce 50% of maximum aggregation after a high sodium intake. The 5-HT2, receptor antagonist ketanserin (1 μmol · 1−1in vitro) reduced the extent of aggregation induced by 5 μmol · 1−1 ADP after the volunteers had taken a high sodium diet, whereas the angiotensin 11 receptor anatgonist saralasin (1 nmol-1−1) increased the rate of aggregation after the low sodium diet.
Thus, during a high sodium intake, human platelets become more sensitive to the aggregating agent ADP It is possible that this effect is mediatedvia platelet 5-HT2 receptors, since ketanserin abolished the increase in salt-induced aggregation seen with 5 μmol · 1−1 ADP.
Key wordsPlatelet aggregation, Ketanserin sodium diet, pharma renin activity, platelet 5-HT2 receptor
Unable to display preview. Download preview PDF.
- 1.Nara Y, Kihara M, Nabika T, Mano M, Horie R, Yamori Y (1984) Dietary effect on platelet aggregation in men with and without a family history of essential hypertension. Hypertension 6:339–343Google Scholar
- 2.Gow IF, Padfield PL, Reid M, Stewart S, Edwards CRW, Williams BC (1987) High sodium intake increases platelet aggregation in normal females. J Hypertens [Suppl] 5:S243–5246Google Scholar
- 3.Ashida T, Tanaka T, Yokouchi M, Kuramochi M, Deguchi F, Kimura P, Kojima S, Ito K, Ikeda M (1985) Effect of dietary sodium on platelet α2-receptors in essential hypertension. Hypertension 7:972–978Google Scholar
- 4.Van-Wersh J, Pereira RR (1983) Platelet aggregation in six families with Bartter's syndrome. Clin Chim Acta 130:363–368Google Scholar
- 5.Stoff JS, Stemerman M, Steer M, Salzuran E, Brown RS (1980) A defect in platelet aggregation in Banter's syndrome. Am J Med 68:171–180Google Scholar
- 6.Moore TJ, Williams GH (1981) Angiotensin II receptors on human platelets. Circ Res 51:314–320Google Scholar
- 7.Ding Y, Maclntyre DE, Kenyon CJ, Semple PF (1985) Potentiation of adrenaline-induced platelet aggregation by angiotensin II. Thromb Haemostas 54:717–720Google Scholar
- 8.Poplawski A (1970) The effect of angiotensin II on the platelet aggregation induced by adenosine-diphosphate, epinephrine, and thrombin. Experientia 26:86Google Scholar
- 9.Parbtani A, Frampton G, Cameron JS (1980) Measurement of platelet release substances in glomerulonephritis: a comparison of beta-thromboglobulin (β-TG), platelet factor 4 (PF4), and serotonin assays. Thromb Res 19:177–189Google Scholar
- 10.Van-Nueten JM (1983) 5-Hydroxytryptamine and precapillary vessels. Fed Proc 42:223–227Google Scholar
- 11.McBride PA, Mann JJ, Nimchinsky E, Cohen ML (1990) Inhibition of serotonin-amplified human platelet aggregation by ketanserin, ritanserin, and the ergoline 5HT2 receptor antagonists - LY53857, sergolexole, and LY237733. Life Sci 47:2089–2095Google Scholar
- 12.DeClerck F, David JL, Janssen PAJ (1982) In: DeClerck F, Vanhoutte PM (eds) Serotonin in peripheral reactions. Raven Press, New York, pp 83–94Google Scholar
- 13.Baumgartner HR, Born GVR (1969) Effect of 5-hydroxytryptamine on platelet aggregation. Nature 201:397–408Google Scholar
- 14.Rademaker M, Lindsey A, McLaren JA, Padfield PL (1987) Home monitoring of blood pressure: usefulness in a prediction of essential hypertension. Scott Med J 32:16–19Google Scholar
- 15.Gow IF, Corrie JET, Williams BC, Edwards CRW (1987) Development and validation of an improved radioimmunoassay for serotonin in platelet-rich plasma. Clin Chim Acta 162:175–188Google Scholar
- 16.Haber E, Koerner T, Page LB, Khman B, Purnode A (1969) Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin in normal human subjects. J Clin Endocrinol Metab 29:1349–1355Google Scholar
- 17.Gow IF, Flapan AD, Morris M, Davies E, Williams BC, Padfield PL, Shaw TRD, Edwards CRW (1991) A lack of effect of captopril on platelet aggregation in patients with congestive heart failure. Ent J Clin Pharmacol 41:47–49Google Scholar
- 18.Al-Dujaili EAS, Edwards CRW (1981) Optimisation of a direct radioimmunoassay for plasma aldosterone. J Steroid Biochem 14:481–487Google Scholar
- 19.Nussberger J, Brunner DB, Waeber B, Brunner HR (1985) True versus immunoreactive angiotensin Il in human plasma. Hypertension 7:11–17Google Scholar
- 20.Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF (1991) Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 84:613–617Google Scholar
- 21.Ding Y, Kenyon CJ, Semple PF (1985) Regulation of platelet receptors for angiotensin Il in man. J Hypertens 3:209–212Google Scholar
- 22.Brezinski DA, Tofler GH, Muller JE, Pohjolhla-Sintonen S, Willich SN, Schafer Al, Czeisler CA, Williams GH (1988) Morning increase in platelet aggregability — association with assumption of the upright posture. Circulation 78:35–40Google Scholar